US Patent 10172845 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Patent 10172845 was granted and assigned to Array Biopharma Inc. on January, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Array Biopharma Inc.

Current Assignee

Array Biopharma Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10172845

Date of Patent

January 8, 2019

Patent Application Number

15861244

Date Filed

January 3, 2018

Patent Citations Received

‌

US Patent 11648243 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

‌

US Patent 10441581 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

‌

US Patent 10881652 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Patent Primary Examiner

‌

Niloofar Rahmani

Patent abstract

Provided herein are compounds of the Formula I:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10172845 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API